Bio View (XTAE:BIOV) ROE % Adjusted to Book Value : 11.85% (As of Jun. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Bio View ROE % Adjusted to Book Value?

Bio View's ROE % for the quarter that ended in Jun. 2024 was 13.86%. Bio View's PB Ratio for the quarter that ended in Jun. 2024 was 1.17. Bio View's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was 11.85%.

Bio View ROE % Adjusted to Book Value Historical Data

The historical data trend for Bio View's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio View ROE % Adjusted to Book Value Chart

Bio View Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

6.09

1.58

4.95

1.16

0.85

Bio View Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-0.22	2.54	6.01	-4.73	11.85

Competitive Comparison of Bio View's ROE % Adjusted to Book Value

For the Medical Devices subindustry, Bio View's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bio View's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio View's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Bio View's ROE % Adjusted to Book Value falls into.

Bio View ROE % Adjusted to Book Value Calculation

Bio View's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	1.38%	/	1.62
	=	0.85%

Bio View's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	13.86%	/	1.17
	=	11.85%

Bio View ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Bio View's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio View Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio View Ltd (XTAE:BIOV) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

3 Pekeris Street, Rehovot, ISR, 7670203

Website

http://www.bioview.co.il

Bio View Ltd is an Israel based company engaged in the research, development, manufacture, marketing, and sale of computerized systems for identification of rate cells and test for detection of cancer. It manufactures and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, pathology clinical and research laboratories. Geographically, the group has its business presence in Israel, USA, and other countries, of which majority of the revenue is derived from the USA.

Bio View Headlines

No Headlines